全文获取类型
收费全文 | 308篇 |
免费 | 7篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 3篇 |
基础医学 | 11篇 |
口腔科学 | 1篇 |
临床医学 | 16篇 |
内科学 | 142篇 |
神经病学 | 3篇 |
特种医学 | 92篇 |
外科学 | 25篇 |
综合类 | 11篇 |
预防医学 | 2篇 |
眼科学 | 1篇 |
药学 | 4篇 |
中国医学 | 1篇 |
肿瘤学 | 4篇 |
出版年
2023年 | 4篇 |
2022年 | 9篇 |
2021年 | 11篇 |
2020年 | 8篇 |
2019年 | 24篇 |
2018年 | 23篇 |
2017年 | 21篇 |
2016年 | 7篇 |
2015年 | 2篇 |
2014年 | 31篇 |
2013年 | 20篇 |
2012年 | 10篇 |
2011年 | 20篇 |
2010年 | 9篇 |
2009年 | 10篇 |
2008年 | 12篇 |
2007年 | 13篇 |
2006年 | 8篇 |
2005年 | 8篇 |
2004年 | 6篇 |
2003年 | 4篇 |
2002年 | 5篇 |
2001年 | 7篇 |
2000年 | 6篇 |
1999年 | 4篇 |
1998年 | 11篇 |
1997年 | 5篇 |
1996年 | 7篇 |
1995年 | 6篇 |
1994年 | 4篇 |
1993年 | 2篇 |
排序方式: 共有317条查询结果,搜索用时 15 毫秒
1.
Zongzhang Huang Qigu Yao Jianping Zhu Ying He Yanghao Chen Feng Wu Teng Hua 《Diagnostic and interventional imaging》2021,102(5):279-285
PurposeThe purpose of this study was to make a systematic review and meta-analysis to determine the stent diameter (8 mm vs. 10 mm) that conveys better safety and clinical efficacy for transjugular intrahepatic portosystemic shunt (TIPS).Materials and methodsFour databases were used to identify clinical trials published from inception until March 2020. Data were extracted to estimate and compare one-year and three-year overall survivals, hepatic encephalopathy, variceal rebleeding, and shunt dysfunction rates between patients with 8 mm covered stents and those with 10 mm covered stents.ResultsFive eligible studies were selected, which included 489 patients (316 men, 173 women). The 8 mm covered stent group had higher efficacy regarding one-year or three-year overall survival (odds ratio [OR], 2.88; P = 0.003) and (OR, 1.81; P = 0.04) and lower hepatic encephalopathy (OR, 0.69; P = 0.04) compared with 10 mm covered stent group. There were no significant differences in variceal rebleeding rate (OR 0.80; P = 0.67). However, shunt dysfunction was lower in 10 mm covered stent group (OR, 2.26; P = 0.003).ConclusionsOur results suggest that the use of 8 mm covered stents should be preferred to that of 10 mm covered stents for TIPS placement when portal pressure is frequently monitored. 相似文献
2.
José Ignacio Bilbao Mercedes Arias Jesús María Longo Pedro Luis Alejandre María Teresa Betés Arlette María Elizalde 《Cardiovascular and interventional radiology》1997,20(2):149-153
Percutaneous embolization of large portosystemic collaterals was performed in three patients following placement of a transjugular
intrahepatic portosystemic shunt in order to improve hepatopetal portal flow. Improved hepatic portal perfusion was achieved
in these cases, thereby theoretically reducing the risk of chronic hepatic encephalopathy. 相似文献
3.
I. Kaare Tesdal Werner Jaschke Mathias Bühler Ralf Adamus Thomas Filser Eggert Holm Max Georgi 《Cardiovascular and interventional radiology》1997,20(1):29-37
Purpose To evaluate prospectively our experience with transjugular intrahepatic portosystemic shunt (TIPS) using four different metallic
stents.
Methods Between November 1991 and April 1995, 57 patients (41 men and 16 women; age 35–72 years, mean 54 years) underwent the TIPS
procedure. Techniques for portal vein localization before and during TIPS were fluoroscopy, computed tomography (CT) studies,
wedged hepatic venography, arterial portography, and ultrasound. After predilation we deployed balloon-expandable (n=48) and self-expanding (n=45) metallic stents. Fifteen patients underwent variceal embolization. Initial follow-up angiograms (mean 6.9 months, range
3–24 months) were obtained in 39 of these patients.
Results Fifty-three patients (93%) had successful TIPS placement. The mean decrease in portal pressure was 42.7%. Besides fluoroscopy,
the most helpful techniques for portal vein localization were venography and CT. Residual stenosis (n=1) and late shortening (n=4) of Wallstents resulted in shunt dysfunction. The technical problems encountered with the Palmaz stent resulted from its
lack of flexibility. We combined balloon-expandable and self-expanding stents in 12 patients. The 30-day and late follow-up
(mean 11.9 months) percutaneous reintervention rates were 11.3% and 64.2%, respectively. There were no clinically significant
complications related to the TIPS insertions.
Conclusion An ideal stent does not exist for TIPS, and the authors recommend combining a Palmaz stent with a flexible self-expanding
stent. 相似文献
4.
J. Menzel O. Schober P. Reimer W. Domschke 《European journal of nuclear medicine and molecular imaging》1997,24(6):635-641
In patients with liver cirrhosis a transjugularly placed intrahepatic portocaval shunt (TIPS) is a non-surgical portosystemic device which aims to reduce portal venons pressure. In comparison with Doppler sonography, we evaluated in 28 patients the diagnostic impact of liver perfusion scintigraphy (with technetium-99m diethylene triamine penta-acetic acid) in the assessment of changes in the hepatic blood flow after TIPS shunting. The arterial and portal contributions to hepatic flow were calculated from the areas under the biphasic timeactivity curve. In the course of TIPS shunting, patency is threatened by reocclusion. Angiography is the gold standard for TIPS shunt reassessment. However, there is a need for a less invasive diagnostic procedure, such as scintigraphy or Doppler sonography, for the early detection of shunt insufficiency. Scintigraphy demonstrated that prior to TIPS shunting the portal venons contribution to hepatic perfusion was reduced to 29.2%, this reduction being due to portal hypertension. After TIPS placement a significant increase in portal venous perfusion was observed (38.2%;P<0.02). TIPS shunt occlusion was identified in patients by a significant reduction in the scintigraphically measured portal venons contribution to hepatic blood flow. Hepatic perfusion scintigraphy appears to be a valuable method to determine the immediate effect of TIPS on hepatic blood flow. Post-TIPS follow-up studies of hepatic haemodynamics by liver perfusion scintigraphy appear able to contribute to the detection of TIPS shunt occlusion before the clinical consequences of this complication have become apparent. 相似文献
5.
6.
P. Rossi M. Bezzi F. M. Salvatori L. Broglia F. Maccioni G. Pizzi S. Abbondanza G. Bonomo 《European radiology》1996,6(5):741-747
The aim of our study was to evaluate the performance and efficacy of a new self-expanding stent (nitinol Strecker stent) in the transjugular intrahepatic portosystemic shunt (TIPS) procedure. We have successfully placed 64 nitinol Strecker stents in 48 patients. The average portosystemic gradient decreased from 22 to 11 mm Hg. Balloon dilatation was necessary in 12 of 35 angiographically controlled cases at 5 days (34%), because of incomplete stent expansion, small thrombi within the stent or obstruction. At 1–6 months stent malfunctions occurred in 8 of 23 patients who underwent control angiography (34%) and at 6–24 months in 6 of 7 patients (85%). Rebleeding occurred in 2 of 39 patients (follow-up > 1 month) (5%) and temporary crises of de novo encephalopathy were observed in 11 of 48 patients (23%). Refractory ascites completely resolved in 4 of 6 patients (66%) and improved in the remaining 2 cases. Compared with other self-expanding stents, nitinol Strecker stents seem to be equally effective in TIPS; no increase in complication rate was observed, either clinical or stent-related.
Correspondence to: P. Rossi 相似文献
7.
Dissection of the portal vein is a rare entity which has been rarely described during transjugular intrahepatic portosystemic
shunt (TIPS) procedure. We report three cases of dissection during this procedure and their complications. One dissection
was immediately treated with coaxial stents. The two others were complicated either by a thrombus or by a false aneurysm.
In the first case a second parallel stent was used to treat this complication. The patient with the portal vein false aneurysm
was transplanted 4 days after this diagnosis. Portal vein dissection in TIPS procedure appeared to be less rare than has been
reported and must be considered as a potential cause of TIPS dysfunction.
Received: 5 May 1999; Revised: 14 July 1999; Accepted: 14 July 1999 相似文献
8.
经皮穿刺直接性门腔静脉分流术的影像学研究 总被引:1,自引:0,他引:1
目的通过对肝硬化并门脉高压症患者的影像学研究,进一步明确肝内门静脉(PV)与肝后段下腔静脉(RHSIVC)的关系,探讨在彩超(CDFI)导引下经皮穿刺行直接性门腔静脉分流(DIPS)术的可行性及安全性。方法随机选择肝硬化并门脉高压症患者30例,利用CDFI、CT、MR进行肝脏二维或三维多切面扫描,并测量RHSIVC长度、被肝实质包绕的RHSIVC长度、以及肝内LPV和RPV距PV分叉部1cm处及PV分叉部与同层面RHSIVC之间的距离。结果三种影像学方法测量的RHSIVC长度、被肝实质包绕的RHSIVC长度、肝内LPV距PV分叉部1cm处与同层面RHSIVC之间的距离、肝内RPV距PV分叉部1cm处与同层面RHSIVC之间的距离、PV分叉部与同层面RHSIVC之间的距离,均无显著性差异(P>0.05)。结论CDFI、CT、MR均能准确显示PV及RHSIVC,RHSIVC起、止层面的横断面平均有56.7%、93.1%的管腔被周围肝实质完全包绕,在CDFI导引下经皮穿刺肝内PV再至RHSIVC行DIPS术是安全、可行的。 相似文献
9.
《Journal of the Chinese Medical Association》2014,77(8):395-402
Acute esophageal variceal hemorrhage is a terrible complication of portal hypertension and. rebleeding is very common in survivors of acute variceal bleeding. Traditional medical management options include the use of vasoconstrictor, balloon tamponade, and endoscopic therapy. Though endoscopic therapy has achieved successful hemostasis in the majority of acute variceal bleeding episodes, the outcome is usually dismal when such therapy fails. Transjugular intrahepatic portosystemic stent shunt (TIPS) was invented to decompress portal hypertension, but is now widely used in Western countries to treat patients with refractory variceal hemorrhage or refractory ascites. By contrast, TIPS has not been commonly used in Asia. In this article, I have reviewed the role of TIPS in the management of portal hypertensive bleeding, which will hopefully be useful for clinicians facing variceal bleeding that is not amenable to endoscopic therapies. 相似文献
10.
Daniel J. Stein Christian Salinas Saher Sabri Rose Onyeali Stephen Caldwell Zachary Henry 《Journal of vascular and interventional radiology : JVIR》2019,30(2):187-194